Rapid-access oncodermatology is associated with reduced corticosteroid use and supports continuation of anticancer therapy after treatment-related cutaneous toxicity

Bibliographic Details
Published in:	JAAD International
Main Authors:	Yuyang Liu, MD, Samuel X. Tan, MD, PhD, Nicholas M. Muller, MD, Xiaohua Shen, MN, Celine Lee, MD, Yit Nah Lau, MD, Victoria Atkinson, MD, Rahul Ladwa, MD, MPhil, Emma-Anne Karlsen, MD, PhD, Kiarash Khosrotehrani, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2026-08-01
Subjects:	adverse events checkpoint inhibitor cIRAE corticosteroid cutaneous toxicity immunotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666328726000805

Internet